In conclusion, we encountered a patient with advanced ICC and a BRCA2 mutation that was successfully treated with neoadjuvant GCS therapy followed by surgical resection, after which a pathologic complete response was achieved. The gene discussed is BRCA2; the disease is intrahepatic cholangiocarcinoma.